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SOCPotassium channels belong to the largest and the most diverse super-families of ion channels. Among them,
Ca2+-activated K+ channels (KCa) comprise many members. Based on their single channel conductance they are
divided into three subfamilies: big conductance (BKCa), intermediate conductance (IKCa) and small conductance
(SKCa; SK1, SK2 and SK3). Ca2+ channels are divided into two main families, voltage gated/voltage dependent
Ca2+ channels and non-voltage gated/voltage independent Ca2+ channels. Based on their electrophysiological
and pharmacological properties and on the tissue where there are expressed, voltage gated Ca2+ channels (Cav)
are divided into 5 families: T-type, L-type, N-type, P/Q-type and R-type Ca2+. Non-voltage gated Ca2+ channels
comprise the TRP (TRPC, TRPV, TRPM, TRPA, TRPP, TRPML and TRPN) and Orai (Orai1 to Orai3) families and their
partners STIM (STIM1 to STIM2). A depolarization is needed to activate voltage-gated Ca2+ channels while non-
voltage gated Ca2+ channels are activated by Ca2+ depletion of the endoplasmic reticulum stores (SOCs) or by
receptors (ROCs). These two Ca2+ channel families also control constitutive Ca2+ entries. For reducing the energy
consumption and for the ﬁne regulation of Ca2+, KCa and Ca2+ channels appear associated as complexes in
excitable and non-excitable cells. Interestingly, there is now evidence that KCa–Ca2+ channel complexes are also
found in cancer cells and contribute to cancer-associated functions such as cell proliferation, cell migration and
the capacity to developmetastases. This article is part of a Special Issue entitled: Calcium signaling in health and dis-
ease. Guest Editors: Geert Bultynck, Jacques Haiech, Claus W. Heizmann, Joachim Krebs, and Marc Moreau.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
K+ channels are the most numerous and diverse ion channels in
living organisms. These ion channels are widespread and regulate nu-
merous functions. For example, they regulate cell excitability in nerve
tissue by contributing to action potentials, whereas in “non-excitable”
cells, they control K+ homeostasis or cell volume. They also regulate
molecular processes, such as hormone secretion. The large number of
genes encoding K+ channels reﬂects the multiple functions of these
channels. Each type of channel has unique electrophysiological and
pharmacological properties. Based on the amino-acid sequences of
the various K+ channel subunits, it is possible to classify them into
four classes: inwardly rectifying K+ channels (Kir channels); tandem
pore domain K+ channels (K2P channel); Ca2+-activated channels
(KCa channels: BKCa, IKCa and SKCa) and voltage-gated K+ channels
(Kv). BKCa channels are activated by changes in membrane potentialSignaling in Health and Disease.
Heizmann, Joachim Krebs, and
, Croissance et Cancer”, Tours F-
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andier).(depolarization) and/or by increases in intracellular Ca2+ concentration.
SKCa and IKCa are not voltage-dependent and are activated by low intra-
cellular Ca2+ concentrations. Through its high Ca2+ sensitivity, SKCa
plays a role in the regulation of signaling pathways involving Ca2+, in
both excitable and non-excitable cells. In excitable cells, such as neurons,
they induce a repolarization or a hyperpolarization that closes voltage-
gated Ca2+ channels or decreases the probability of their activation,
thereby decreasing intracellular Ca2+ concentration. Their activation in
non-excitable cells, such as epithelial/endothelial cells, increases Ca2+
entry through non-voltage gated Ca2+ channels, by increasing the Ca2+
driving force, leading to an increase in intracellular Ca2+ concentration.
Regulation of intracellular Ca2+ homeostasis involves both entry from
extracellular space and Ca2+ from intracellular sources (endoplasmic
reticulum; ER, mitochondria). The ubiquitous second messager Ca2+ is
involved in many fundamental physiological functions, such as cell
cycle control, survival, apoptosis, migration and gene expression. For
each cellular function, speciﬁc spatial and temporal characteristics are re-
quired. Thus, altered Ca2+ signaling has been suggested as an important
event in driving the expression ofmalignant phenotypes, such as prolifer-
ation, migration, invasion and metastases. Among Ca2+ entry pathways,
two major classes of plasma calcium permeable channels mediate Ca2+
entry in response to various stimuli. Voltage-gated Ca2+ channels (Cav),
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gated calcium channel including transient receptor potential (TRP)
family, Store Operated Channels (SOCs) and Store- independent Ca2+
channels (Arachidonate-regulated Ca2+ channel) that require two
partners Orai (Ca2+ channel) and STIM (ER protein). Cav are mostly
expressed in excitable cellswhereas the non-voltage gatedCa2+ channels
are the major Ca2+ entry pathways in non-excitable cells.
During the last decade, KCa channels were found to be expressed in
various cancers. Moreover, among this KCa channel family, the SK3
channel SKCa has been described as selectively expressed in aggressive
cancers and implicated in metastasis development by interacting with
Orai1, a speciﬁc voltage independent Ca2+ channel. This complex is
essential to activate Ca2+-regulated stimulatory pathways for cell mi-
gration and bone metastases. Here we review the studies that present
evidence of the complex's formation between KCa and Ca2+ channels
and their potential involvement in cancer.
2. KCa and Ca2+ channels
2.1. KCa channels
2.1.1. Generalities
Potassium channels belong to the largest and the most diverse
super-family of ion channels. Given the K+ channel diversity, a K+
Channel Nomenclature (KCN) was developed based on the name of
the genes encoding for K+ channel subunits (http://www.genenames.
org/genefamilies/IC). The family of Ca2+-activated K+ channels (KCa)
comprises manymembers that exhibit different single channel conduc-
tance and pharmacological proﬁles.Fig. 1. KCa channels. Based on their single channel conductance, Ca2+-activated potassium cha
intermediate KCa (IKCa/KCa3.1) and small conductance KCa (SKCa) channels. There are three isofo
to form tetramers, with β/γ subunits for BKCa or without known auxiliary subunit for SKCa/IKCaAccording to IUPHAR (International Union of Pharmacology; http://
www.iuphar-db.org/DATABASE/ReceptorFamiliesForward?type=IC),
KCa channels belong to 6TM/1P (6 transmenbrane segments/1 pore do-
main) family and can bedivided into three subfamilies: big conductance
(BKCa), intermediate conductance (IKCa) and small conductance
(SKCa) (Fig. 1). SKCa, included SK1, SK2 and SK3 (KCNN1, 2, 3, KCa2.1,
2.2, 2.3 SK1, 2, 3), BKCa included KCa1.1 (KCNMA1 ou Slo ou Slo1) and
IKCa is also named KCa3.1 or SK4 or IK1 [1]. KCa channels are formed
by a main α subunit and, for BKCa, by additional regulatory subunits.
The α subunit contains 6 (IKCa and SKCa) or 7 (BKCa) TM. Four alpha
subunits are necessary to form a functional KCa channel. The selectivity
ﬁlter for K+ ions and the pore of the channel are formed by the loop be-
tween the ﬁfth and sixth TM domains. SKCa and IKCa channels are
voltage-insensitive and activated by low concentrations of intracellular
Ca2+, in contrast to BKCa, which is activated by both voltage and intra-
cellular Ca2+. By hyperpolarizing plasmamembranes KCa channels reg-
ulate neuronal and smooth muscle excitabilities. In neurons, they
mediate the afterhyperpolarization (AHP) that follows a neuronal ac-
tion potential (a more negative resting potential than the resting one).
There are three AHP components (fast, medium and slow AHP) and
while BKCa is believed to be responsible for the fast AHP [2], SKCa con-
trol medium AHP but not slow AHP [3].
2.1.2. BKCa channel
Since its discovery by Marty et al. in chromafﬁn cells [4], the α BKCa
subunit has been found in the central nervous system and in peripheral
tissues.
This channel is voltage and Ca2+ dependent. It activates for
membrane potential higher than 20 mV and for intracellular Ca2+nnels (KCa channels) are divided into three families that include large or big KCa (BKCa),
rms of SKCa subunits, named SK1/KCa2.1, SK2/KCa2.2, SK3/KCa2.3. Theα subunit associates
.
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regulates the resting membrane potential through its activation by
spontaneous Ca2+ release by the peripheral sarcoplasmic reticulum
[5–7]. It plays a negative feedback controller role in excitation–contrac-
tion coupling by limiting smooth muscle cell depolarization and con-
tractions [8]. In contrast to the voltage-independent SKCa and IKCa,
which detect Ca2+ indirectly through association with calmodulin
(CaM) [9,10], BKCa directly binds Ca2+ at its C-terminal region. There
are three Ca2+ binding sites; two high afﬁnity sites the “Ca2+ bowl”
[11] and the RCK domain (Regulatory of Conductance of K+) [12] and
the low Ca2+ afﬁnity binding site localized in the RCK domain.
Although BKCa activity is increased by membrane depolarization
and by intracellular Ca2+ concentration, its activation is primarily in-
duced by the voltage and not by Ca2+ [13–15]. Ca2+ acts as an ampliﬁer,
increasing channel activity at concentrations higher than 100 nM.
Below this threshold, the channel works in a Ca2+-independent mode
and becomes purely voltage-dependent with a V1/2 (voltage required
for half-maximal Po (open probability)/activation) of 200 mV [13].
When the channelworks in a Ca2+dependentmode theV1/2 linearly in-
creasewith pCa (free Ca2+). The unique and singular properties of BKCa
suggest that, in order to be active, it should colocalizewith a Ca2+ chan-
nel or regulatory subunits that modulate its voltage and/or Ca2+
sensitivity.
The α subunit of the channel possesses a S0 segment which by its
transmembrane position directs the N-terminal to extracellular side
and allows the association with β subunits [16,17]. There are four
β subunits (β 1–4 encoding by KCNMB) with 2 transmembrane seg-
ments connected with a large extracellular segment. These β subunits
modulate its inactivation and deactivation kinetics as well as its inward
rectiﬁcation, Ca2+ sensitivity and toxin binding [13,15,18–24]. Globally,
β subunits were found to differentially increase the Ca2+ sensitivity of
BKCa. The effect of theβ4 subunit on Ca2+ sensitivitywas somewhat in-
consistent in previous reports [21,25,26]. However, Ha et al. demon-
strated that BKCa channel activation by Ca2+ became more
cooperative by the coexpression of the β4 subunit [24]. Interestingly,
the presence of β2 and β3 subunits resulted in rapid inactivation of
BKCa currents, and β3 was found to induce inward rectiﬁcation of the
current–voltage relationship [19–23].
Additional group of auxiliary proteins to BKCa, the γ subunits,
consists of proteins with a conserved leucine-rich repeat (LLCRs) that
can dramatically modify BKCa channel activation [27,28]. Indeed, the
LRRC26 induces a Ca2+-independent leftward shift of ~140 mV in the
opening probability vs. voltage curve. Other γ subunits are LRRC52
(γ2), LRRC55 (γ3) and LRRC38 (γ4) [28]. Interestingly, BKCa channels
open at resting membrane potentials and low intracellular Ca2+ in the
presence of γ subunits that are expressed in prostate cancer [28].
BKCa is blocked by several toxins such as Iberiotoxin, Paxilline and
by low concentrations of extracellular Tetraethylammomium salt
(TEA), and is activated by NS1608 and NS1619 [1]. Toxins are useful
pharmacological tools to discriminate between KCa channels: BKCa is
blocked by Iberiotoxin but not by Apamin, which speciﬁcally blocks
SKCa channels. IKCa channels, which are not sensitive to Apamin and
Iberiotoxin, are blocked by Charybdotoxin, this latter also inhibiting
BKCa [29–32].
2.1.3. IKCa channel
Already in 1958 intracellular Ca2+ was shown to regulate K+ efﬂux
in red blood cells [33]. 26 years later patch clamp experiments revealed
that the activation of a K+ channel was responsible for this regulation
[34]. The channel was cloned in 1997 [35–37] and is known under
the names of IKCa, KCa3.1, SK4 or IK1. IKCa belongs to 6TM/1P channel
family with a close SKCa structure.
Unlike for SKCa channels, the expression of IKCa transcripts was not
found in excitable cells such as neurons and skeletal or heart muscles
but mainly in the salivary glands, the placenta and the lungs [38]. On
the other hand this channel was described to play an important role inlymphocytes activation [37,39]. Afterward, this channel was sporadically
detected in some neurons where its role was not clearly established ex-
cept for neurons from myenteric plexus where it was found to regulate
the AHP [40,41].
Compared to SKCa channels IKCa have a larger conductance of about
40 pS at a symmetrical K+ concentration (the identical concentration of
K+ in extra- and intracellular media) [35,36,38] and like for the SKCa
current an inward rectiﬁcation was described. The activation of this
channel is not dependent on voltage but on intracellular Ca2+ concen-
tration [35,36]. This is conferred by CaM binding in the C-term end of
the channel, in a similarwayas for SKCa [9]. Furthermore, theC-term re-
gion localized just after the pore of the channel is conserved with SKCa,
and as demonstrated for SKCa, CaM can bind IKCa in the absence of
Ca2+. The origin of the intracellular Ca2+ elevation that activates IKCa
depends on the cell type, but it is well accepted that in lymphocytes
this is realized by Store Operated Ca2+ Entry activation [42,43].
Several papers have reviewed the pharmacological regulation of
IKCa [44,45]. Brieﬂy, IKCa is inhibited by various toxins, of which
maurotoxin is the most selective one with an IC50 of about 1 nM [46].
Interestingly, maurotoxin produces no inhibition of SK1, SK2, SK3 and
BKCa at up to 1 μM [46]. IKCa is also inhibited by Charybdotoxin,
which, however, also acts on BKCa and Kv1.3 [29–32]. On the other
hand, IKCa is also inhibited by various small molecules, the two being
most used are Clotrimazole and TRAM-34. TRAM-34 is the most selec-
tive inhibitor of IKCa and was derived from Clotrimazole [47]. IKCa
activators have also been synthesized, including benzimidazolone and
benzothiazole compounds. These molecules are however not selective
to IKCa, since they also activate SKCa channels.
2.1.4. SKCa channels
The genes coding for SKCa channels were cloned in 1996 [48].
Although they show no voltage sensitivity [48–50], the fourth trans-
membrane segment of the α subunit is positively charged, memory of
the voltage-sensitive segment of Kv channels. The SKCa channels retain
only two of the seven positively charged amino acids that are found in
the S4 segment of Kv channels, and only one of these residues corre-
sponds to the four arginine residues that carry the gating charges in
Kv channels [48,51]. SKCa have been described in the central nervous
system [50] but also in various cell types in the peripheral system,
such as the skeletal muscle cells [52], the glandular cells [53] or the T
lymphocytes [54].
There are three different genes encoding SKCa proteins, SK1, SK2,
and SK3, which form channels with a conductance between 4 and
14 pS. They are mainly found in the central nervous system [55] as well
in peripheral tissues, especially SK2 and SK3, while SK1 was detected
almost exclusively in neuronal tissues [56].
Although the activation of SKCa channels is voltage independent,
their current–voltage relationship shows an inward rectiﬁcation that is
the consequence of a voltage-dependent block by intracellular divalent
cations [48,51]. Indeed, at positive membrane potentials, Ca2+ not only
activates but also blocks SKCa channels in a concentration-dependent
manner. Interestingly, this block is inﬂuenced by extracellular K+, as
observed for inward rectiﬁcation K+ channels family [57,58]. Low
concentrations of intracellular Ca2+ (300–700 nM) activate SKCa chan-
nels to 50%, and the Hill coefﬁcients of 3–5 that were deduced from
Ca2+-concentration response curves show a high degree of cooperativity
for the Ca2+-dependent activation of SKCa channels [10,51]. This suggests
that the binding of more than one Ca2+ ion is necessary and that positive
cooperative binding occurs [10].
The CaM binding site at the proximal portion of the C-terminus at
each α subunit is highly conserved for the different SKCa subfamilies
and is called CaM-binding domain (CaMBD) [59]. A SKCa channel has
4 CaMBD sites and 4 CaMwould interact with CaMbinding sites. The in-
teraction between CaM and SKCa channel α subunits is constitutively
maintained in the presence or absence of Ca2+. SKCa channel activation
requires each α subunit to be linked to CaM. CaM associated with each
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Ca2+ binding to CaM induces conformational rearrangements in CaM,
which are transferred to the α-subunit, and results in SKCa channel
opening. TheN-terminal EFHands of CaM (sites 1 and2) are responsible
for Ca2+-dependent gating in SKCa channels whereas the C-terminal
domain (sites 3 and 4) are necessary for Ca2+-independent constitutive
binding of CaM to SKCa [61].
The pharmacology of SKCa has already been discussed in excellent
reviews [62–67]. Brieﬂy, the modulation of SKCa channels by chemicals
mainly occurs via three mechanisms: interaction with the pore of the
channels (inhibitors or “pore blockers” such as Apamin), modiﬁcation
of the sensitivity of the channel to the cytosolic Ca2+ concentration
(both inhibitors and activators) and amphiphilic structures acting by
integration into the membrane (such as Ohmline).2.2. Ca2+ channels
2.2.1. Non-voltage gated (voltage independent) Ca2+ channels
In 1883, Sydney Ringer was the ﬁrst to highlight the important role
of Ca2+ in cardiac contraction in the frog [68]. Since then numerous
studies have shown the role of Ca2+ in many cellular processes such
as muscle contraction, fertilization, secretion and differentiation.
Changes in cytosolic Ca2+ trigger events critical for tumorigenesis,
such as cellular migration, proliferation or apoptosis.
There are mainly two types of intracellular Ca2+ increase: following
the release of intracellular stores (SOCE: Store Operated Ca2+ Entry),
and the inﬂux from the extracellularmedium. The responsible ion chan-
nels for the former are the SOCS (Store Operated Channels), the CRAC
(Ca2+-Release Activated Ca2+ channel) being their archetype, and for
the latter the chemo-dependent channels or SIC (Store Independent
Ca2+ Channels). SIC include ROCs (Receptor Operated Channels),
which are directly activated in response to extracellular signals to
surface receptors without intracellular signalization, and SMOCs
(Second Messenger Operated Channels), which are activated by
an intracellular ligand (Diacyglycerol (DAG), phospholipase A2
(PLA2) or arachidonic acid (AA)) generated by the activation of G
protein-coupled receptor.
The concept of SOCE was proposed in 1986 [69], but the molecular
components of this pathway were not identiﬁed for almost two de-
cades. Direct evidence in support of thismodel was provided by electro-
physiological studies on Jurkat T cells and mast cells where the process
of store depletion activated a Ca2+ current called Ca2+ release activated
Ca2+ current or ICRAC [70,71]. ICRAC is non-voltage activated, inwardly
rectifying, and highly selective for Ca2+ [72,73]. The single-channel con-
ductance of ICRAC is ~15 fS [74] (total CRAC current fromanentire cell is
only ~5–10pA) [75]. This slow, tiny but highly Ca2+-selective CRAC cur-
rent is the ﬁrst and best characterized for SOCE.
The ﬁrst candidate protein for a SOC was isolated from Drosophila
melanogaster and called TRP (transient receptor potential) [76] which
became the perfect prototype of channels activated by depletion of
intracellular stores of Ca2+ [77,78]. Twenty-one genes code for proteins
homologous to TRP and TRPL (TRP-Like) channels in Drosophila.
TRP channels represent a new family which includes more than 50
cation-permeable channels. There are seven TRPC isoforms (TRPC1 to
TRPC7), six TRPV (TRPV1 to TRPV6), and eight TRPM (TRPM1 to
TRPM8) and TRPN, TRPA1, TRPP (TRPP1 to TRPP3) and TRPML (TRPML1
to TRPML3) [79]. On the structural level, the TRP super family adopts
the same topology of 6 TM, similar to voltage gated K+ channels. A
small hydrophobic segment between the ﬁfth and sixth TM domains
participates in the formation of the pore channel. Like most channels
with six TM domains, they are functional in homo- or heterotetramers.
The S4 domain acts as a transmembrane electric sensor, giving a low volt-
age dependence for TRPs [80] (Fig. 2A).Whereas all TRP channels are per-
meable for various cations, only two are impermeable for Ca2+ (TRPM4,
TRPM5), and two others are highly Ca2+ permeable (TRPV5, TRPV6).At their N-termini, TRPC, TRPN and TRPV families have four ankyrin
repetition domains, one of the most common protein–protein interac-
tion motifs. Furthermore, TRPV6 and all TRPC contain interaction sites
with CaM. The TRPC family constitutes a major subclass of the seven
TRP subfamilies sofar identiﬁed to be regulated by store depletion
[81–83]. Several studies on various cell lines have shown that TRPC4
and sometimes C5 can be activated by store depletion [84,85]. However,
a new molecular identity to SOC channel may consist of a complex
between STIM1 (Stromal Interacting Molecule 1) [86,87] and Orai1
[43,87] which were discovered as a result of a high-throughput screen-
ing by RNA interference (RNAi). In 2005, two groups independently
screened Drosophila S2 and HeLa cells, and identiﬁed STIM as the
molecule that senses ER Ca2+ levels and activates the opening of SOC
channels on the plasmamembrane [86,87]. In 2006, three other groups
performed a pedigree analysis of inheritable severe combined immuno-
deﬁciency (SCID) patients whose lymphocytes lacked CRAC current. By
genome-wide RNAi screening in Drosophila and human cells [43,88,89]
Orai1 (or CRACM1 for CRAC modulator 1) was found to be another key
molecule involved in SOCE. Subsequent studies have conﬁrmed that
Orai1 is the pore-forming protein of the SOC/CRAC channel [74,90,91].
Co-expression of STIM1 and Orai1 generates a huge CRAC like current
[89,92,93], implying that the two molecules comprise the essential
machinery for SOCEs [94–96].
STIM1 is the Ca2+ sensor of ER Ca2+ stores [86,97]. The STIM1 is
located on the human chromosome 11p15.5 [98]. A second gene,
STIM2was identiﬁedwith a structure very similar to STIM1 and is located
on the human chromosome 4p15.2. Both proteins contain a single SAM
domain and an EF-hand motif near the N-terminus, which is located
in the ER lumen, which predicts a role of STIM1/2 in sensing ER Ca2+.
The cytosolic portion contains two coiled-coil domains, a Pro/Ser-rich
and a Lys-rich stretch. The CRAC activation domain (CAD) is functionally
recognized as the activation domains of Orai1 [99]. The protein STIM1 is
expressed at both the cell surface and the ER, whereas STIM2 protein is
expressed only in intracellular space [100]. STIM1 is known to have a
dual role of ER Ca2+ sensor and transducer information to present to
SOCs the plasma membrane. Depletion of intracellular Ca2+ stores
causes rapid translocation and the formation of clusters of STIM1 is nec-
essary for CRAC channel activation to the plasma membrane [101]. If
STIM1 appears as a mediator of activation of SOCs, STIM2 is a potent in-
hibitor of this process, interferingwith the action of STIM1 in preventing
it from forming an aggregate. The opposite functions of STIM1 and
STIM2 suggest that they may play a role in the control of Ca2+ entry
via SOCs. STIM2 has been described as a feedback regulator that stabi-
lizes basal concentrations of Ca2+ cytosol and ER. The suppression of
STIM2 reduces cytosol and ER Ca2+ concentration whereas its overex-
pression leads to increase them [102].
Human Orai are plasma membrane proteins predicted to contain
four TM segments (TM1 to TM4) with both N- and C-termini located in
the cytosol. There are three isoforms of the Orai (Orai1, Orai2, Orai3)
which are capable to formhomo as heterotetramers [103] (Fig. 2B). In ad-
dition, the coexpression of STIM1, Orai2 andOrai3 also leads to the activa-
tion of a SOC but with different biophysical properties [103]. Orai1
includes a Proline-rich domain at its N-terminus and a coiled-coil domain
at the C-terminus. The R91W mutation, located in TM1, was found in
severe combined immunodeﬁciency (SCID) patients and abrogates
Ca2+-release-activated Ca2+ (CRAC) channel activity [43].
Concerning the role of TRP in SOCE, several studies have demon-
strated a role of STIM1 in activating TRPC channels and regulating
SOCE where STIM1 interacts with TRPC1 C2, C4 and C5 (for review
[104]). Moreover, TRPC1 has been described to interact with Orai1
and STIM1 [105–108] and plasma membrane lipid rafts domains seem
to determine the peripheral clustering of STIM1 and regulation of
TRPC1-mediated SOCE [109–111]. However, the critical role of Orai1
in activation of TRPC1-SOC channels following Ca2+ store depletion
has not yet been established but recent studies have showed a regula-
tion of the surface expression of TRPC1 by Orai1 and gating by STIM1
Fig. 2. Ca2+ channels are divided into non-voltage gated or voltage independent channels (TRP: transient receptor potential; Orai) and voltage gated or voltage dependent channels (Cav).
A) TM topology of TRP. α subunit consisting of six TM domains with the N- and C-termini located in the cytoplasm. Between the ﬁfth and sixth TM domains, which are highly conserved
among all the homologues, there is a re-entrant pore loop (P). B) TM topology of Oraiα subunit. Each has four TM spanning domains,with intracellular N and C termini. CRAC channel pore
is formed from a tetramer of Orai1 subunits. ARC channel pore is formed from a pentameric assembly of Orai1 andOrai3 subunits. N-terminal cytosolic domain inOrai3 plays a critical role
in sensitivity of the ARC channel to arachidonic acid. C)α subunit structure of Cav channels. Each subunit is organized in four homologous domains (I–IV), with six TM segments (S1–S6)
each. The S4 segment is the voltage sensor and the pore loop is comprised between TM segments S5 and S6. An intracellular β subunit and α2δ subunit complex are components of most
types of Ca2+ channels. Aγ subunit has been found in skeletalmuscle Ca2+ channels, and related subunits are expressed inheart and brain. Although these auxiliary subunitsmodulate the
properties of the channel complex, the pharmacological and electrophysiological diversity of Ca2+ channels is linked to the multiple α1 subunits.
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is activated by agonists acting on a range of G-protein-coupled recep-
tors. There is a clear overlap between the functional roles played by
SOCE and SMOC entry. There is a subtle distinction between one re-
sponse, initiated by receptor activation but potentiated by the release
of Ca2+ from intracellular stores and another initiated by store deple-
tion as a consequence of receptor activation. Thus it is not surprising
that, from a molecular point of view, both SOC and SMOC channels
may be formed from proteins belonging to the same family. TRP chan-
nels initially were regarded as having a role in forming SOCs, however,
many of their properties are consistent with them forming SMOCs.
Thus, the association of TRPC5 with either TRPC1 [113] or TRPC4 [114]
forms non-selective cation channels activated by G-protein coupled
receptors, but not store depletion, as does expression of TRPC6 alone
[115,116]. TRPC6, TRPC7 and TRPC3 have been reported to form chan-
nels activated directly by DAG [117,118]. TRPV4 contributed to an
ATP-induced increase inmouse airway epithelial cells, providing a path-
way for ROC entry but not SOCE [119]. Receptor-activated TRPC3, TRPC4
and TRPV4 may contribute to the regulation of Ca2+ entry and activity
of endothelial vasodilator factors [120,121].
The Orai family includes store-independent Ca2+ channels or SMOC,
arachidonic acid (AA)-regulatedARC channels [122,123]. TheARC chan-
nel is a small conductance, highly Ca2+-selective ion channel whose
activation is speciﬁcally dependent on low concentrations of arachidonic
acid acting at an intracellular site [124]. The ARC channel pore is formedby a heteropentameric assembly of Orai1 and Orai3 subunits [125]
(Fig. 2B). Like SOC channels, ARC channels depend on STIM1 for their
activation, but whereas CRAC channel activation involves sensing the
depletion of intracellular Ca2+ stores via a luminal N terminal EF-hand
of STIM1 in the endoplasmic reticulum membrane, ARC channels are
exclusively activated by the pool of STIM1 that constitutively resides in
the plasma membrane [126,127]. In the same manner, activities of
many TRP channels are regulated by lipids as PIP2 (phosphatidylinositol
4,5-bisphosphate), DAG or AA that can act as endogenous agonist. Thus,
TRPV1, V3 and V4 can be activated by polyunsaturated fatty acids and
AA metabolites [121,128–130]. Other studies have showed that TRPM8
is regulated by the Ca2+-independent phospholipase A(2) (iPLA(2)) sig-
naling pathwaywith its end products, lysophospholipids (LPLs), acting as
its endogenous ligand [131,132].
2.2.2. Voltage gated (voltage dependent) Ca2+ channels
Among the major classes of plasma membrane Ca2+-permeable
channels, voltage-gated Ca2+ channels (Cav) have been the ﬁrst de-
scribed to control Ca2+ entry in excitable cells. They can also contribute
to the regulation of Ca2+ entry in non-excitable cells (T-cells/cancer
cells). However the mechanism by which Ca2+ enters electrically in
non-excitable cells is unclear. Cav channels are heteromultimers that
are composed of a pore-forming α1 subunit, β regulatory subunit, and
α2, γ, and δ subunits [133]. The α1 pore subunit is predicted to have
four repeated motifs (I–IV), each of which is hexahelical and contains
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channel pore (Fig. 2C). The S4 transmembrane segment in each motif
contains conserved positively charged amino acids that are voltage sen-
sors and that move outwards upon membrane depolarization, thereby
opening the channel.
Since the ﬁrst recordings of Ca2+ currents in cardiac myocytes [134],
the classiﬁcation of Ca2+ channel has been based on electrophysiological
criteria associated with pharmacological criteria after the discovery of
speciﬁc toxins [135–137].
According to these criteria, Ca2+ channels were divided into low-
voltage activated (LVA) and high-voltage-activated (HVA). LVA Ca2+
channels activate at a membrane voltage positive to−60 mV. Because
of the small amplitude of single channel conductance and its fast
decay, these channels were also called T-type Ca2+ channels (T for
tiny and transient). HVA channels have an activation threshold at
membrane voltages positive to−40mV. The ﬁrst generally known rep-
resentative of the HVA channel family was found abundant in skeletal,
smooth and cardiac muscles as well as in neurons. Because of its
large-single channel conductance amplitude and slow kinetics of
current decay, it was named L-type Ca2+ channel (L for large and
long-lasting) in contrast to the T-type. A pharmacological hallmark of
all L-type channels is their sensitivity to 1,4-DHPs — a wide class of
drugs with either inhibitory (Nifedipine, Nisoldipine, Isradipine).
Experiments with neuronal cells revealed novel Ca2+ channels, in-
sensitive to DHPs and with single-channel conductance between those
of T-type and L-type channels [138,139]. These channels were named
N-type Ca2+ channels (N for neuronal). Neuronal non-L-type channels
can be further classiﬁed into subtypes according to their sensitivity
to peptide toxins isolated from cone snails and spiders. The channel sen-
sitive toω-Conotoxin kept the name N-type channel, while the channel
sensitive to ω-Aga toxin was named P/Q-type channel [140]. The chan-
nels resistant to these toxins were named R-type Ca2+ channel (R for
resistant).
The α1 subunit is responsible for basic electrophysiological and
pharmacological properties that formed the basis of channel classiﬁca-
tions. Several α1 subunits representing class L-type Ca2+ channels
were identiﬁed. The ﬁrst one, the α1 subunit from skeletal muscle was
puriﬁed [141] and named α1S (CACNA1S) [142]. Later, α1 subunit was
cloned from cardiac (CACNA1C) (α1C-a, [143]) and smooth muscle
(α1C-b, [144]). L-type subfamilieswere identiﬁed later:α1D (CACNA1D)
([145]; and α1F (CACNA1F) [146]). Three α1 subunits, representing the
third neuronal types of Ca2+ channels, were cloned. α1A subunit
(CACNA1A) [147,148] corresponds to the P/Q-type channel. α1B sub-
units (CACNA1B) [149] match with N-type channel. α1E subunit
(CACNA1E) [150] was initially characterized as an LVA T-type channel.
Later studies demonstrated that it has the properties of R-type channel.
Three members of the LVA T-type subfamily were identiﬁed: α1G
(CACNA1G) [151], α1H (CACNA1H) and α1I (CACNA1I). As the number
of cloned Ca2+ channel α1 subunits increased a systemic nomenclature
was deﬁned: the Cavx.y scheme [152], where Cav stands for voltage-
activated Ca2+ channel (VACC), x designating L-type, N-type and
T-type, and y is a number designating individualmembers of subfamilies.
3. KCa–Ca2+ complexes
Despite the advancements over the past two decades in deﬁning the
expression and the role of channel proteins in cancer, many questions
remain unanswered. For example, as channel proteins are hijacked
from their normal physiological function: could KCa and Ca2+ channels
form channel complexes in transformed cells, or in the context of tu-
mors differ from those formed in a physiological context? Are these
complexes linked to particular membrane structures (e.g.: some lipid
rafts) speciﬁcally associated to malignant transformation or to the
tumor microenvironment? Answering these questions should help to
develop potent and speciﬁc inhibitors of these complexes in order to
design therapeutic approaches speciﬁcally targeting tumor cells.A depolarization is needed to activate voltage-gated Ca2+ channels
while non-voltage gated Ca2+ channels are activated following Ca2+
ER depletion (SOCs), receptor activation (ROCs) or are constitutively ac-
tive. A constitutive Ca2+ entry can also be observed for voltage-gated
Ca2+ channels and for membrane potentials in which there is an over-
lap between the activation and inactivation curves, so that there is a
window ofmembrane potentials overwhich a fraction of Ca2+ channels
are activated but not inactivated. This is known as the Ca2+ window
current. The increase of intracellular Ca2+ concentration through both
voltage-gated and non-voltage gated Ca2+ channels activates KCa chan-
nels (Fig. 3ab). KCa activation by regulating the membrane potential
would in turn alter the intracellular Ca2+ concentration depending on
the voltage sensitivity of Ca2+ channels; the activation of KCa channels
in excitable cells, such as neurons or smooth muscle cells, induces a
repolarization or a hyperpolarization that closes voltage-gated Ca2+
channels, thereby decreasing intracellular Ca2+ inﬂux through voltage
gated Ca2+ channels (Fig. 3cd). In this case KCa channels play a crucial
role in this negative feedback loop. In contrast, the activation of KCa
channels in non-excitable cells, such as epithelial/endothelial cells, in-
creases Ca2+ entry through non-voltage gated Ca2+ channels. This in-
creases the Ca2+ driving force, leading to an increase in intracellular
Ca2+ concentration (Fig. 3d). In this case KCa channels play a crucial
role in this low-energy cost and positive feedback loop.
Table 1 reports publications that have established an association be-
tween KCa and Ca2+ channels in excitable and non-excitable cells. BKCa
is the most frequent KCa channel associated with Ca2+ channels. Ca2+
channels provide sufﬁcient Ca2+ for BKCa activity, acting as Ca2+ ampli-
ﬁers. BKCa appears to be associated to voltage-gated and non-voltage
gated Ca2+ channels in excitable and non-excitable cells, suggesting a
role for this channel in either negative or positive feedback loops.
SKCa and IKCa appear to be mostly expressed with voltage gated Ca2+
channels in excitable cells and with non-voltage gated Ca2+ channels
in non-excitable cells respectively, suggesting a major role in the nega-
tive feedback loops for SKCa and positive feedback loops for IKCa. Inter-
estingly, the SK3 channel switches from an association with voltage
gated Ca2+ channels in excitable cells to non-voltage gated Ca2+ chan-
nels in cancer cells. This switch is believed to be used by cancer cells to
increase Ca2+ entry subsequent to a positive feedback loop [153].
4. Role of KCa–Ca2+ channel complexes in the biology of cancer cells
and tumor development
If in a physiological context, KCa and Ca2+ channels regulate neuro-
nal and smooth muscle excitabilities, this is not that is observed in a
tumor context. Their physiological function is hijacked by cancer cell
to drive essential biological functions for tumor development such as
cell migration [176–179]. KCa and Ca2+ channels have been found in
many and various tumor cell lines, such as prostate cancer, breast can-
cer, gliomas, melanoma colon cancer and other tumors. These channels
regulate functions such as cell proliferation and cell migration and this
has been reviewed by several groups [67,177,178,180–186].
In this review we focused on recent ﬁndings demonstrating that
KCa–Ca2+ channel complexes are also found in cancer cells that confer
to these cells new biological functions such as cell proliferation and cell
migration (Table 2).
Among them, we have demonstrated a pivotal role of SK3–Orai1
complex in cancer cell migration and bone metastasis development
[153]. When SK3 channel is expressed in human breast and prostate
epithelial cancer cells it co localize with Orai1 channel in lipid rafts
(SK3 channel was not observed in normal human breast and prostate
epithelial cells in contrast to Orai1 channel). The two channels form a
complex acting independently of STIM1 and regulating a singular
mode for Orai1-dependent Ca2+ entry.Wepropose to refer to this path-
way as to a constitutive Ca2+ entry.We have been able to show that the
disruption of SK3–Orai1 complexes by the alkyl-lipid Ohmline impaired
the constitutive Ca2+ entry, cell migration and bone metastases. It is
Fig. 3.Non-voltage gated (voltage insensitive) and voltage gated (voltage sensitive) Ca2+ channels working as ion channel complexeswith KCa channels. SOCs; Store Operated Channels,
ROCs; Receptor Operated Channels. a, d: positive feedback loop between KCa and Ca2+ channels, b, c: negative feedback loop between KCa and Ca2+ channels.
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from clinical samples were shown positive for a membrane-bound co-
localized form of SK3 and Orai1. This strongly emphasizes the clinical
consistency of our observations. We believe that formation of a SK3–
Orai1 complex represents the gain of a new biological function, notTable 1
Expression of KCa–Ca channel complexes in non-tumor cells. MVN;medial vestibular nucleus, D
cortical collecting duct, PBMC: peripheral bloodmononuclear cells, coPI: CoImmunoprecipitatio
VGCa: voltage gated Ca2+ channels, N-VGCa: Non-voltage gated Ca2+ channel, and ND: not de
Cell type KCa VGCa
Rat brain BKCa L-type Ca2+ cha
Rat brain BKCa Cav1.2 / Cav2.1
Mesenteric artery SMC BKCa Cav1.2
Hippocampal neurons BKCa N-type Ca2+ ch
Neocortical neurons BKCa L/N-type Ca2+ c
Chromafﬁn cells BKCa L/Q-type Ca2+ c
tsA-201 BKCa Cav3.2
MVN
Hair cells BKCa VGCa
Hair cells KCa VGCa
HEK293 BKCa
DRG cells
Cerebral SMC BKCa
HBE cell lines BKCa
Aorta SMC BKCa
HEK293 BKCa
Podocytes
M-1 cell line -BKCa
HEK293 SK2 (alpha-actinin2) Cav1.2 / Cav1.3
Atrial and ventricular cardiac cells
Hippocampal neurons SKCa L-type Ca2+ cha
Dopaminergic midbrain neurons SKCa T-type Ca2+ cha
Cerebral artery -IKCa
-SK3
PBMC Macrophages IKCa
HEK293
MLS-9 microglia cells IKCa
Human T lymphocytes IKCa
Endothelial cells IKCaexisting either through individual protein or when the complex is not
integrated into lipid rafts. This suggests that the evolving cancer cell
could take advantage of the association and retargeting of two ion chan-
nels. SK3 and Orai1 are probably not the only actors of this constitutive
Ca2+ entry. Indeed, a constitutive store independent Ca2+ entry that isRG: Dorsal root ganglia, SMC: smoothmuscle cells, HBE: human bronchial epithelial, M-1:
n, IF: immunoﬂuorescence, IH: immunohistochemistry, KCa: Ca2+-activated K+ channels,
termined.
N-VGCa Co-localization Refs
nnel coIP and IH [154]
/ Cav2.2 coIP [155]
IF [156]
annel ND [157]
hannel ND [158]
hannel ND [159]
coIP and IF [160]
IF [161]
IF [162]
TRPV1 coIP and IF [163]
TRPV4/RyR ND [164]
TRPV4 ND [165]
TRPC1 coIP and IF [166]
TRPC3 / TRPC6 coIP and IF [167]
TRPV4 ND [168]
coIP and IF [169]
nnel ND [157]
nnel ND [170]
TRPA1 IF [171]
SOC ND [172]
Orai1/SOC IF [173]
TRPM7 ND [174]
TRPV4 Ca2+ imaging ﬂuorescence [175]
Table 2
Expression and biological functions of KCa–Ca channel complexes in tumor cells and tumor tissues. PCa: prostate cancer, LNM: metastatic lymph node samples, coPI:
CoImmunoprecipitation, IF: immunoﬂuorescence, IH: immunohistochemistry, KCa: Ca2+-activated K+ channels, VGCa: voltage gated Ca2+ channels, N-VGCa: Non-voltage gated Ca2+
channel.
Cell type KCa VGCa N-VGCa Co-localisation Biological cell function Refs
LNCaP PCa cell line BKCa Cav3.2 coIP and IF Proliferation [187]
LNCaP PCa cell line IKCa TRPV6 coIP Proliferation [188]
MDA-MB-435 s breast cancer cell line SK3 Orai1 IF and IH Migration [153]
Breast and Prostate tumor tissues
MDA-MB-231 breast cancer cell line HEag1 (not a KCa) Orai1 IH Migration [189]
Breast adenocarcinoma tissues and LNM
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been described in breast cancer cells [190]. SPCA isoforms are important
in sequestering Ca2+ and Mn2+ from the cytoplasm into the Golgi and
post-Golgi vesicles. The two isoforms, SPCA1 (ATP2C1) and SPCA2
(ATP2C2) share signiﬁcant sequence similarity, but have distinct distri-
bution and function [191]. SPCA1 is ubiquitously expressed in mamma-
lian tissues. In contrast, expression of SPCA2 is conﬁned to highly
secretory or absorptive epithelia, including the mammary gland, testis,
salivary glands, intestinal tract, lung, and brain [192]. In breast cancer
cells, Feng et al. showed that SPCA2 mRNA levels are upregulated
and increased cell proliferation. The mechanism responsible revealed
the ability of SPCA2 to be localized at the plasmamembrane and to elicit
a constitutive Ca2+ entry by an unconventional link between NH2-
terminus SPCA2 and Orai1 [190]. The role of KCa channels in this com-
plex is not known.
Interestingly, a recent paper describes a role for BKCa–Cav3.2 com-
plex in the proliferation of LNCaP prostate cancer cells by controlling a
constitutive Ca2+ entry [187]. BKCa–Cav3.2 complex, by maintaining
membrane potentials within a window of membrane potentials over
which a fraction of Cav3.2 are activated but not inactivated allows
Ca2+ to constitutively enter the cells through this Ca2+window current.
This means that for these membrane potentials which are controlled by
BKCa, Cav3.2 channels are open and support some entry of Ca2+
(we named constitutive Ca2+ entry). Furthermore, this constitutive
Ca2+ entry would activate BKCa channels that regulate membrane po-
tential working as a positive feedback loop (see Fig. 3). In this case
Ca2+ acts as a modulator of BKCa activity thus controlling the mem-
brane potential. Note that this Ca2+ window current did not activate
IKCa channels (also expressed in these cells). A major difference be-
tween IKCa/SKCa and BKCa is the presence of regulatory subunits that
could increase the Ca2+ sensitivity of BKCa channel. We can speculate
that the Ca2+ window current is too small to reach the Ca2+ activation
threshold of IKCa in contrast to BKCa. Since, it was found in LNCaP cells
that the expression of γ subunits opens BKCa at resting membrane
potentials and low intracellular Ca2+ [28,193], the necessary role of
Cav3.2 for BKCa activity has to be determined.
IKCawas found to associate onlywith non-voltage gated Ca2+ chan-
nels both in tumor and non-tumor cells (see Tables 1 and 2). In LNCaP
prostate cancer cells IKCa channel regulates Ca2+ entry through
TRPV6 by controlling the electrochemical gradient for Ca2+ [188].
Moreover, immunoprecipitation experiments indicated a close physical
interaction between the IKCa and TRPV6 in these cells [188]. In the same
manner, the Human Ether a'-gogo potassium Channel 1 (hEag1) has
been shown to regulate breast cancer cell migration through Orai1-
dependent Ca2+ entry [189]. This complex has been found in invaded
lymph nodes where high hEag1 level was associated with high Orai1
level expression [189]. However, in these two studies, the nature of
Ca2+ entry (constitutive or capacitive) remains to be explored.
Similarly, the modiﬁcation of expression or activity of other types of
channel complex has been described to be involved in the disease pro-
cess by decreasing the intracellular Ca2+ concentration. In glioma cell
lines, TRPC1 channels, localize to the leading edge of migrating cells,
where it has been correlated with EGF-mediated directional migration[194,195]. Interestingly TRPC1 that mediates Ca2+ entry seems to
colocalize with the chloride channel ClC-3 in caveolar lipid rafts of
glioma cells [196]. In ﬁbrosarcoma cells, Cav3.1 channels have also
been linked to metastatic behavior, probably in association with TRP
channels [197].
5. Conclusion and future directions
In this reviewwe focused on the KCa and Ca2+ ion channel families.
Since Ca2+ activates KCa that pass through Ca2+ channels, their associ-
ation as complexes seems to be an efﬁcient and the economic way for
their mutual ﬁne regulation. There is now evidence that KCa and Ca2+
channels, alone or associated in complexes, play important roles in the
proliferation and migration of cancer cells, crucial for metastatic devel-
opment. Additional research is required to determine the role of these
complexes in tumor development (primary tumor and/or metastatic
development) and their clinical relevance. Many questions remain
unanswered: Are KCa–Ca2+ channel complexes different in tumor
cells compared to physiological context? Are these complexes linked
to particular membrane structures (e.g. lipid rafts) associated with
either malignant transformation or tumor microenvironment?
Answering these questions should help to develop potent and
speciﬁc inhibitors of these complexes in order to design therapeutic
approaches speciﬁcally targeting tumor cells. In this way we join our
efforts and expertise within a French network named IonChannel-
Canceropole Grand Ouest (IC-CGO; www.ic-cgo.fr). The IC-CGO project
relies on a network composed of 19 partners from Grand Ouest region
(including 2 platforms) with transversal, complementary and multidis-
ciplinary approaches. The key objectives to be addressed by the IC-CGO
network consist of complementary tasks: 1) to identify signaling com-
plexes composed of KCa and Ca2+ channels involved in cancer cell
migration and survival; 2) to determine the clinical relevance of these
channels in breast cancer, prostate cancer, chronic lymphocytic leuke-
mia and chronic myeloid leukemia; 3) to discover and develop new
active modulators of these channels and complexes; 4) to develop ap-
propriate cellular models for drug screening and ion channel probes
for diagnostic and therapeutic approaches and 5) to test compounds
on existing in vitro and in vivo platforms. We believe that this network
will combinebasic and clinical research through collaborations between
clinicians, chemists and biologists, and allow us to propose KCa and
Ca2+ channels as new relevant drug targets and prognostic indicators
for breast cancer, prostate cancer and leukemia.
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